Stockreport

BRIEF-Roche Receives FDA Approval For Cervical Cancer Prevention Test [Reuters]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF BRIEF-Roche Receives FDA Approval For Cervical Cancer Prevention Test March 11 (Reuters) - Roche Holding AG: * ROCHE RECEIVES FDA APPROVAL FOR CINTEC PLUS CYTOLOGY TEST [Read more]